Page 22 - Let them speak Towards a patient reported outcome measure set for

Chapter 1
20. McKenna SP. Measuring patient-reported outcomes: moving beyond misplaced common
sense to hard science. BMC medicine. 2011;9(1):1–12.
21. Administration USFaD. Clinical Outcome Assessment (COA): Frequently Asked Questions
2020 [Available from: https://www.fda.gov/about-fda/clinical-outcome-assessment-coa-
frequently-asked-questions#COADefinition.
22. Raat H, Landgraf J, Bonsel G, Gemke R, Essink-Bot M-L. Reliability and validity of the child
health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Quality of Life
Research. 2002;11:575–81.
23. Müller AR, Luijten MA, Haverman L, de Ranitz-Greven WL, Janssens P, Rietman AB, et al.
Understanding the impact of tuberous sclerosis complex: development and validation of the
TSC-PROM. BMC medicine. 2023;21(1):1–15.
24. Beurskens AJ, de Vet HC, Kökeb AJ, Lindeman E, van der Heijden GJ, Regtope W, et al. A
patient-specific approach for measuring functional status in low back pain. Journal of
manipulative and physiological therapeutics. 1999;22(3):144–8.
25. Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LE, et al. Patient‐reported
outcome measures (PROMs): A review of generic and condition‐specific measures and a
discussion of trends and issues. Health Expectations. 2021.
26. Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and
why? Quality of Life Research. 2009;18(1):115–23.
27. Damman OC, Jani A, de Jong BA, Becker A, Metz MJ, de Bruijne MC, et al. The use of PROMs
and shared decision‐making in medical encounters with patients: an opportunity to deliver
value‐based health care to patients. Journal of evaluation in clinical practice. 2020;26(2):524–
40.
28. Haverman L, van Oers HA, van Muilekom MM, Grootenhuis MA. Options for the Interpretation
of and Recommendations for Acting on Different PROMs in Daily Clinical Practice Using KLIK.
Med Care. 2019;57 Suppl 5 Suppl 1:S52–S8.
29. Greenhalgh J, Gooding K, Gibbons E, Dalkin S, Wright J, Valderas J, et al. How do patient
reported outcome measures (PROMs) support clinician-patient communication and patient
care? A realist synthesis. Journal of patient-reported outcomes. 2018;2:42.
30. Gibbons C, Porter I, Goncalves-Bradley DC, Stoilov S, Ricci-Cabello I, Tsangaris E, et al. Routine
provision of feedback from patient-reported outcome measurements to healthcare providers
and patients in clinical practice. Cochrane Database Syst Rev. 2021;10:CD011589.
31. Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover AM, et al. Symptom monitoring with
electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT
cluster-randomized trial. Nature Medicine. 2025:1–8.
32. Haverman L, Van Oers HA, Limperg PF, Hijmans CT, Schepers SA, Sint Nicolaas SM, et al.
Implementation of Electronic Patient Reported Outcomes in Pediatric Daily Clinical Practice:
The KLIK Experience. Clinical Practice in Pediatric Psychology. 2014;2(1):50–67.
33. Haverman L, van Rossum MAJ, van Veenendaal M, van den Berg JM, Dolman KM, Swart J,
et al. Effectiveness of a Web-Based Application to Monitor Health-Related Quality of Life.
Pediatrics. 2013;131(2):e533–e43.
34. Engelen V, Detmar S, Koopman H, Maurice-Stam H, Caron H, Hoogerbrugge P, et al. Reporting
health-related quality of life scores to physicians during routine follow-up visits of pediatric
oncology patients: Is it effective? Pediatric Blood & Cancer. 2011;58(5):766–74.
35. Stover AM, Haverman L, van Oers HA, Greenhalgh J & Potter CM. Using an implementation
science approach to implement and evaluate patient-reported outcome measures (PROM)
initiatives in routine care settings. Quality of Life Research. 2021;30(11):3015–33.
36. Rivera SC, Kyte DG, Aiyegbusi OL, Slade AL, McMullan C, Calvert MJ. The impact of patient-
reported outcome (PRO) data from clinical trials: a systematic review and critical analysis.
Health and quality of life outcomes. 2019;17:1–19.
37. EMA. Patient experience data in medicines development and regulatory decision-making.
https://www.ema.europa.eu/en/events/multi-stakeholder-workshop-patient-experience-data-
medicines-development-regulatory-decision-making#documents-section2022.
38. FDA. FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation
of the Patient’s Voice in Medical Product Development and Regulatory Decision Making.
20